Fig. 3.
Function of in vivo FL-generated PBMCs.
Alloreactive T-cell–stimulating capacities of PBMCs from day-0 (•) and day-15 PB (▴) samples from the same donor were compared. Data represent the mean ± SEM of triplicate wells. Results from a representative FL-treated donor and the corresponding placebo-treated individual from the 25-μg/kg cohort are presented. Similar results were seen with PBMCs from other FL-treated donors.